Insmed Inc. buy Morgan Stanley
Start price
04.08.23
/
50%
€20.00
Target price
04.08.24
€37.17
Performance (%)
16.00%
Price
03.05.24
€23.60
Summary
This prediction is currently active. The prediction currently has a performance of 16.00%. This prediction currently runs until 04.08.24. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Insmed Inc. | 2.609% | 2.609% |
iShares Core DAX® | -0.922% | -1.078% |
iShares Nasdaq 100 | 0.371% | -0.556% |
iShares Nikkei 225® | 2.224% | -2.825% |
iShares S&P 500 | -0.026% | -0.788% |
Comments by Morgan_Stanley for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $41.00 price target on the stock.
Ratings data for INSM provided by MarketBeat